116 related articles for article (PubMed ID: 10721974)
1. Reversible atorvastatin-associated external ophthalmoplegia, anti-acetylcholine receptor antibodies, and ataxia.
Negevesky GJ; Kolsky MP; Laureno R; Yau TH
Arch Ophthalmol; 2000 Mar; 118(3):427-8. PubMed ID: 10721974
[No Abstract] [Full Text] [Related]
2. Alopecia associated with atorvastatin.
Segal AS
Am J Med; 2002 Aug; 113(2):171. PubMed ID: 12133763
[No Abstract] [Full Text] [Related]
3. Rhabdomyolysis in a patient receiving atorvastatin and fluconazole.
Kahri J; Valkonen M; Bäcklund T; Vuoristo M; Kivistö KT
Eur J Clin Pharmacol; 2005 Feb; 60(12):905-7. PubMed ID: 15625612
[No Abstract] [Full Text] [Related]
4. [Atorvastatin . A new generation of hypolipemic agents?].
Azanza JR; Sádaba B; Quetglas EG
Rev Med Univ Navarra; 1998; 42(1):51-5. PubMed ID: 10420957
[No Abstract] [Full Text] [Related]
5. Summaries for patients. Treatment trials to determine whether statins are the cause of a patient's discomfort.
Ann Intern Med; 2014 Mar; 160(5):I-34. PubMed ID: 24737270
[No Abstract] [Full Text] [Related]
6. Safety of statin therapy in patients with mitochondrial diseases.
Hannah-Shmouni F; Al-Sarraf A; Frohlich J; Mezei MM; Sirrs S; Mattman A
J Clin Lipidol; 2013; 7(2):182. PubMed ID: 23415441
[No Abstract] [Full Text] [Related]
7. Atorvastatin-induced cholestatic hepatitis in a young woman with systemic lupus erythematosus. Grupo Lupus Virgen de las Nieves.
Jiménez-Alonso J; Osorio JM; Gutiérrez-Cabello F; López de la Osa A; León L; Mediavilla García JD
Arch Intern Med; 1999 Aug 9-23; 159(15):1811-2. PubMed ID: 10448788
[No Abstract] [Full Text] [Related]
8. Atorvastatin calcium: an addition to HMG-CoA reductase inhibitors.
Chong PH; Seeger JD
Pharmacotherapy; 1997; 17(6):1157-77. PubMed ID: 9399600
[TBL] [Abstract][Full Text] [Related]
9. Cholestatic jaundice induced by atorvastatin: a possible association with antimitochondrial antibodies.
Minha S; Golzman G; Adar I; Rapoport M
Isr Med Assoc J; 2009 Jul; 11(7):440-1. PubMed ID: 19911499
[No Abstract] [Full Text] [Related]
10. Efficacy and safety of rosuvastatin and atorvastatin in patients with hypercholesterolemia and a high risk of coronary heart disease: a randomized, controlled trial.
Schwartz GG; Bolognese MA; Tremblay BP; Caplan R; Hutchinson H; Raza A; Cressman M
Am Heart J; 2004 Jul; 148(1):e4. PubMed ID: 15215813
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia.
Lee SH; Chung N; Kwan J; Kim DI; Kim WH; Kim CJ; Kim HS; Park SH; Seo HS; Shin DG; Shin YW; Shim WJ; Ahn TH; Ho Yun K; Yoon MH; Cha KS; Choi SW; Han SW; Hyon MS
Clin Ther; 2007 Nov; 29(11):2365-73. PubMed ID: 18158077
[TBL] [Abstract][Full Text] [Related]
12. Lipid-altering changes and pleiotropic effects of atorvastatin in patients with hypercholesterolemia.
Sakabe K; Fukuda N; Wakayama K; Nada T; Shinohara H; Tamura Y
Am J Cardiol; 2004 Aug; 94(4):497-500. PubMed ID: 15325939
[TBL] [Abstract][Full Text] [Related]
13. [Proximal myopathy secondary to statin treatment in a patient with Hashimoto thyroiditis].
Ferreiro JL; Dapena Mdel C; Suárez RL; Pérez-Argüelles BS; Vázquez CM
Endocrinol Nutr; 2009; 56(7):387. PubMed ID: 19883901
[No Abstract] [Full Text] [Related]
14. Aggressive statin treatment, very low serum cholesterol levels and haemorrhagic stroke: is there an association?
Athyros VG; Tziomalos K; Karagiannis A; Wierzbicki AS; Mikhailidis DP
Curr Opin Cardiol; 2010 Jul; 25(4):406-10. PubMed ID: 20375883
[TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy and safety of low-dose pitavastatin versus atorvastatin in patients with hypercholesterolemia.
Sansanayudh N; Wongwiwatthananukit S; Putwai P; Dhumma-Upakorn R
Ann Pharmacother; 2010 Mar; 44(3):415-23. PubMed ID: 20179259
[TBL] [Abstract][Full Text] [Related]
16. A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial.
Illingworth DR; Crouse JR; Hunninghake DB; Davidson MH; Escobar ID; Stalenhoef AF; Paragh G; Ma PT; Liu M; Melino MR; O'Grady L; Mercuri M; Mitchel YB;
Curr Med Res Opin; 2001; 17(1):43-50. PubMed ID: 11464446
[TBL] [Abstract][Full Text] [Related]
17. Atorvastatin and the ability of clopidogrel to inhibit platelet aggregation.
Shechter M
Circulation; 2003 Jun; 107(22):e210; author reply e210. PubMed ID: 12796420
[No Abstract] [Full Text] [Related]
18. Ptosis, diplopia and statins: an association?
Elsais A; Lund C; Kerty E
Eur J Neurol; 2008 Oct; 15(10):e92-3. PubMed ID: 18727677
[No Abstract] [Full Text] [Related]
19. Atorvastatin (Lipitor).
Tucker G
Conn Med; 1998 May; 62(5):283-5. PubMed ID: 9639958
[No Abstract] [Full Text] [Related]
20. Acquired cerebellar ataxia due to statin use.
Teive HA; Munhoz RP; Werneck LC
Arq Neuropsiquiatr; 2012 Feb; 70(2):152. PubMed ID: 22311222
[No Abstract] [Full Text] [Related]
[Next] [New Search]
